72 companies

GlaxoSmithKline Pharmaceuticals

Market Cap: ₹465.4b

Manufactures, distributes, and trades in pharmaceuticals in India and internationally.

500660

₹2,747.05

7D

0.4%

1Y

45.8%

Medpace Holdings

Market Cap: US$9.1b

Provides clinical research-based drug and medical device development services in North America, Europe, and Asia.

MEDP

US$297.72

7D

3.7%

1Y

-24.6%

Novartis

Market Cap: CHF 163.4b

Engages in the research, development, manufacture, distribution, marketing, and sale of pharmaceutical medicines in Switzerland and internationally.

NOVN

CHF 86.09

7D

-6.5%

1Y

-0.01%

Abbott India

Market Cap: ₹628.5b

Operates as a pharmaceutical company in India.

500488

₹29,578.60

7D

1.8%

1Y

11.8%

Protagonist Therapeutics

Market Cap: US$2.5b

A biopharmaceutical company, develops peptide therapeutics for hematology and blood disorders, and inflammatory and immunomodulatory diseases.

PTGX

US$42.62

7D

-4.1%

1Y

57.6%

Xiamen Amoytop Biotech

Market Cap: CN¥31.2b

Engages in research, development, production, and sale of recombinant protein drugs in China.

688278

CN¥76.61

7D

-2.2%

1Y

21.2%

Torrent Pharmaceuticals

Market Cap: ₹1.1t

Engages in the research, development, manufacturing, and marketing of generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally.

500420

₹3,127.50

7D

-4.8%

1Y

21.4%

ChemoMetec

Market Cap: DKK 8.0b

Engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally.

CHEMM

DKK 458.20

7D

7.8%

1Y

55.3%

Orion Oyj

Market Cap: €6.7b

Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.

ORNBV

€47.94

7D

-8.8%

1Y

45.3%

Blue Jet Healthcare

Market Cap: ₹118.6b

Engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products.

BLUEJET

₹683.55

7D

-5.9%

1Y

74.5%

Henan Lingrui Pharmaceutical

Market Cap: CN¥12.7b

Produces and sells medicines in China.

600285

CN¥22.63

7D

0.1%

1Y

2.0%

Exelixis

Market Cap: US$9.9b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

EXEL

US$35.31

7D

2.1%

1Y

54.8%

Hunan Jiudian Pharmaceutical

Market Cap: CN¥8.3b

Researches, develops, produces, and sells pharmaceutical products in China and internationally.

300705

CN¥16.82

7D

-10.4%

1Y

-32.9%

Cosmo Pharmaceuticals

Market Cap: CHF 741.5m

Focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide.

COPN

CHF 46.30

7D

-10.4%

1Y

-33.1%

Ajanta Pharma

Market Cap: ₹320.4b

A specialty pharmaceutical formulation company, together with its subsidiaries, develops, manufactures, and markets speciality pharmaceutical finished dosages.

AJANTPHARM

₹2,565.40

7D

3.2%

1Y

21.3%

Jamjoom Pharmaceuticals Factory

Market Cap: ر.س10.4b

Manufactures and markets pharmaceutical products in the Kingdom of Saudi Arabia and internationally.

4015

ر.س151.80

7D

6.0%

1Y

15.0%

EZZ Life Science Holdings

Market Cap: AU$68.9m

Engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and internationally.

EZZ

AU$1.46

7D

0%

1Y

73.8%

Shanghai Allist Pharmaceuticals

Market Cap: CN¥39.4b

Shanghai Allist Pharmaceuticals Co., Ltd.

688578

CN¥87.45

7D

-2.1%

1Y

89.2%

Agilent Technologies

Market Cap: US$29.3b

Provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.

A

US$102.71

7D

-0.3%

1Y

-27.0%

Imeik Technology DevelopmentLtd

Market Cap: CN¥55.2b

Engages in the research and development, production, and transformation of biomedical soft tissue repair materials in China.

300896

CN¥183.08

7D

1.1%

1Y

-11.6%

Mega Lifesciences

Market Cap: ฿24.0b

Manufactures and sells health food supplements, prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods in Southeast Asia and Sub-Saharan Africa.

MEGA

฿27.50

7D

-6.8%

1Y

-32.9%

Consun Pharmaceutical Group

Market Cap: HK$7.8b

Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.

1681

HK$9.36

7D

1.6%

1Y

63.1%

SKAN Group

Market Cap: CHF 1.4b

Provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Europe, the Americas, Asia, and internationally.

SKAN

CHF 61.10

7D

-1.5%

1Y

-25.7%

Chugai Pharmaceutical

Market Cap: JP¥10.3t

Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.

4519

JP¥6,286.00

7D

-5.5%

1Y

20.0%

Zhangzhou Pientzehuang Pharmaceutical

Market Cap: CN¥123.7b

Engages in the manufacture and sale of Chinese medicines under the Pien Tze Huang brand in China and internationally.

600436

CN¥205.00

7D

1.1%

1Y

-5.3%

Lotus Pharmaceutical

Market Cap: NT$56.3b

Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.

1795

NT$212.00

7D

-8.6%

1Y

-38.0%

Caplin Point Laboratories

Market Cap: ₹142.1b

Engages in the development, production, marketing, and export of generic pharmaceutical formulations and branded products in India.

524742

₹1,869.40

7D

-3.5%

1Y

44.5%

hVIVO

Market Cap: UK£109.7m

Operates as a pharmaceutical service and contract research company in the United Kingdom.

HVO

UK£0.16

7D

11.2%

1Y

-44.0%

PeptiDream

Market Cap: JP¥241.5b

A biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics.

4587

JP¥1,863.00

7D

-3.9%

1Y

20.4%

Genmab

Market Cap: DKK 77.7b

A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.

GMAB

DKK 1,225.00

7D

-2.1%

1Y

-40.7%

Catalyst Pharmaceuticals

Market Cap: US$2.7b

A commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States.

CPRX

US$22.05

7D

-4.4%

1Y

44.9%

Tianjin Pharmaceutical Da Ren Tang Group

Market Cap: CN¥20.4b

Produces and sells traditional Chinese medicine, western medicine, and other products primarily in the People’s Republic of China.

600329

CN¥30.38

7D

-3.4%

1Y

-3.8%

NATCO Pharma

Market Cap: ₹138.9b

A pharmaceutical company, engages in the developing, manufacturing, and marketing of finished dosage formulations, active pharmaceutical ingredients (APIs), and intermediates in India, the United States, and internationally.

NATCOPHARM

₹775.50

7D

-2.7%

1Y

-20.4%

Sichuan Biokin PharmaceuticalLtd

Market Cap: CN¥97.9b

Engages in the research and development, production, and marketing of small molecule chemical, macromolecular biological, and antibody-drug conjugate drugs in China and internationally.

688506

CN¥244.20

7D

-2.4%

1Y

87.3%

Jagsonpal Pharmaceuticals

Market Cap: ₹14.0b

Engages in the manufacturing, selling, and trading of pharmaceutical products and active pharmaceutical ingredients in India and internationally.

JAGSNPHARM

₹210.72

7D

-2.4%

1Y

79.5%

PharmaEngine

Market Cap: NT$12.1b

A biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan.

4162

NT$84.00

7D

-15.0%

1Y

-13.5%

Page 1 of 2